Each year, 2.2 million people are diagnosed with lung cancer,1 and by 2030, lung cancer deaths per year are set to increase drastically2 in the absence of urgent, coordinated global action. For instance, in the US only 21.8% of people with lung cancer will survive up to five years.3 This is why, in 2021, the Lung Ambition Alliance held a session at the World Economic Forum’s Sustainable Development Impact Summit on Delivering the Promise of SDG 3.4: Reducing Premature Mortality from Lung Cancer. One of the outcomes of the summit was the establishment of the Lung Cancer Collaboration (LCC), which brings together organizations in healthcare delivery, research, diagnostics, biopharma, patient advocacy and non-governmental organizations behind the overall objective of eliminating lung cancer as a leading cause of death.

Three workstreams have been established within the LCC, focusing on early detection and screening, improving quality of care, and finance and infrastructure. Each workstream has been tasked with developing recommendations that will shape the future of lung cancer.